Clinical Trial Update: Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of fludarabine, carboplatin, topotecan, and thalidomide in relapsed/refractory acute myeloid leukemia, chron…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Fludarabine (Fludarabine)
• Thalidomide (thalidomide)
• Topotecan (topotecan)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED